Keyword: Venrock Associates
The measure of success for 10x Genomics is not the IPO dollar amount, but instead the discoveries made by researchers using its hardware, the CEO said.
Encoded Therapeutics' work is based on a platform designed to overcome hurdles it has identified in the gene therapy space.
Hitting the IPO target would bring the preclinical anti-aging startup’s fundraising haul up toward $300 million.
The new funding will propel Unity Biotechnology's osteoarthritis asset into its first clinical trial.
Biohaven Pharmaceutical has filed to raise up to $100 million in an IPO for clinical trials of drugs it picked up from AstraZeneca and Bristol-Myers Squibb.